Search Results

Now showing 1 - 1 of 1

Add to my favorites
COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
(Springer Nature, 2020) Ferrandis, R. (Raquel); Hidalgo, F. (Francisco); Sierra, P. (Pilar); Cassinello, C. (Concepción); Llau, J.V. (Juan V.); Gómez-Luque, A. (Aurelio); Quintana, M. (Manuel)
The novel infection caused by coronavirus SARS-CoV-2 determining COVID-19 disease causes alterations mainly in the respiratory system. Many reports have postulated a procoagulant state accompanying the respiratory distress with thrombosis at both venous and arterial levels [1]. The procoagulant pattern is characterized by hyperfibrinogenemia and elevated D-dimer levels, with mild thrombocytopenia and a moderately prolonged prothrombin time [2]. Although D-dimers are not specific indicators of clot formation, in combination with the other parameters, its elevation may suggest a systemic coagulation activation with an increase of thrombin generation and fibrinolysis.